CHEMICALLY MODIFIED QUINOLINE AND QUINOLONE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS
申请人:Janssen Pharmaceutica NV
公开号:US20170057922A1
公开(公告)日:2017-03-02
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the CB1 receptor. Such compounds are represented by Formula (I)
wherein R
1
, R
2
, R
3
, L
1
, n, v, r, w, and g are defined herein.
and further represented by Formula (II)
wherein the group “X═Y”, ring A, R
10
, R
11
, R
30
, W, and t are defined herein.